Correction: Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Yingwei Zhang; Zeyu Zhang; Chundi Li; Donge Tang; Yong Dai

doi:10.1039/D3MO90012F

Correction: Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Yingwei Zhang,*^a Zeyu Zhang,^b Chundi Li,^a Donge Tang^b and Yong Dai*^b

* Corresponding authors

^a Department of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen 518000, China
E-mail: 18653133290zyw@sina.com
Tel: +86-18565668800

^b The Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen 518020, China
E-mail: daiyong22@163.com
Tel: +86-0755-22942780

Abstract

Correction for ‘Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin’ by Yingwei Zhang et al., Mol. Omics, 2022, 18, 643–651, https://doi.org/10.1039/D2MO00036A.

Molecular Omics

Correction: Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Abstract

Associated articles

Article information

Download Citation

Search articles by author

Spotlight

Advertisements